Skip to main content
BEBETTER MED INC. logo

BEBETTER MED INC. — Investor Relations & Filings

Ticker · 688759 ISIN · CNE100007CZ3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 62 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688759

About BEBETTER MED INC.

http://www.bebettermed.cn/

BEBETTER MED INC. is a clinical-stage company dedicated to the discovery and development of innovative small molecule therapeutics. The organization focuses on addressing unmet medical needs within the fields of oncology, metabolic disorders, and autoimmune diseases. Its research and development pipeline features a range of proprietary drug candidates, with a particular emphasis on targeted therapies and kinase inhibitors. By leveraging advanced drug discovery platforms, the company identifies and optimizes lead compounds to advance through clinical evaluation. BEBETTER MED INC. oversees the entire development lifecycle, including preclinical research, clinical trial management, and the pursuit of regulatory approvals for its therapeutic candidates.

Recent filings

Filing Released Lang Actions
中信证券股份有限公司关于广州必贝特医药股份有限公司2025年度持续督导跟踪报告
Regulatory Filings Classification · 92% confidence The document is a "持续督导跟踪报告" produced by the sponsor (中信证券) under Shanghai Stock Exchange and CSRC continuous supervision requirements. It is neither the company’s own annual/interim report nor an earnings release, audit report, or proxy. Rather, it is a compliance/regulatory filing by the sponsor summarizing oversight activities, findings, risk analysis, and financial data. This falls under the general "Regulatory Filings" (RNS) category as a miscellaneous compliance document.
2026-05-20 Chinese
中信证券股份有限公司关于广州必贝特医药股份有限公司2025年度持续督导工作现场检查报告
Regulatory Filings Classification · 85% confidence The document is an on-site inspection report conducted by the sponsor (CITIC Securities) under continuous supervision requirements of the Shanghai Stock Exchange for the period up to December 31, 2025. It details the sponsor’s review of governance, internal control, information disclosure, related transactions, use of funds, and operational status. It is not an annual or interim financial report, earnings release, proxy statement, or management discussion but rather a specific compliance report under regulatory self‐discipline guidelines. This falls under miscellaneous regulatory filings that do not fit other specific categories, so it should be classified as Regulatory Filings (RNS).
2026-05-20 Chinese
中信证券股份有限公司关于广州必贝特医药股份有限公司首次公开发行网下配售部分限售股上市流通的核查意见
Regulatory Filings Classification · 95% confidence The document is a formal verification opinion from a sponsor (中信证券股份有限公司) regarding the listing and circulation of restricted shares from the initial public offering (IPO) of Guangzhou Bibete Pharmaceutical Co., Ltd. It references regulatory approvals, share lock-up periods, and compliance with securities laws. The content focuses on the sponsor's review and confirmation of the restricted shares' circulation compliance, not on financial results or earnings. It is not an annual or interim report, earnings release, or management discussion. It is a regulatory compliance and verification document related to share issuance and listing. This fits best under Regulatory Filings (RNS) as it is a regulatory compliance announcement and verification opinion rather than a financial report or capital update filing. The document length is short and focused on compliance verification, not a full report or announcement of a report publication.
2026-04-20 Chinese
首次公开发行网下配售部分限售股上市流通的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the listing and circulation of restricted shares from the company's initial public offering (IPO) offline placement. It details the number of shares becoming tradable, the dates, shareholder commitments, and regulatory approvals. It references regulatory approvals and compliance with securities laws but does not contain financial statements or performance data. The document is relatively short (2230 characters) and serves as an official notice about share circulation rather than a financial report or detailed filing. Therefore, it fits best as a Regulatory Filing (RNS) since it is a regulatory announcement about share listing and circulation without being a full financial report or capital change announcement.
2026-04-20 Chinese
湖南启元律师事务所关于广州必贝特医药股份有限公司2026年第一次临时股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of a company's 2026 first extraordinary general meeting (临时股东会). It details the legality and validity of the meeting's procedures and voting results. The document does not contain financial statements or performance data, nor is it a report of financial results or management discussion. It is a legal opinion related to a shareholder meeting and voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially confirms the voting results and legality of the shareholder meeting proceedings.
2026-04-08 Chinese
2026年第一次临时股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 2026 first extraordinary general meeting (临时股东会决议公告) of Guangzhou Bibete Pharmaceutical Co., Ltd. It details the meeting date, attendance, voting results, and legal witness statements. It does not contain financial statements or detailed financial analysis but reports on shareholder meeting outcomes and voting results. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1380 characters), and it is not a report publication announcement or a regulatory filing. Therefore, the correct classification is DVA with high confidence.
2026-04-08 Chinese

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.